Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy

Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy

ABSTRACT: Objectives: Ceftolozane/tazobactam (C/T) is a novel cephalosporin and β-lactamase inhibitor combination with great activity against Pseudomonas aeruginosa. To assess P. aeruginosa susceptibility to C/T, a surveillance study was conducted from October 2018 to March 2019 at the University H...

Full description

Bibliographic Details
Main Authors: Gianluca Morroni, Lucia Brescini, Alberto Antonelli, Vincenzo Di Pilato, Sefora Castelletti, Andrea Brenciani, Gloria D'Achille, Marina Mingoia, Eleonora Giovanetti, Simona Fioriti, Annamaria Masucci, Tommaso Giani, Andrea Giacometti, Gian Maria Rossolini, Oscar Cirioni
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Ceftolozane/tazobactam
Pseudomonas aeruginosa
β-lactamase
Online Access:http://www.sciencedirect.com/science/article/pii/S221371652200176X

Internet

http://www.sciencedirect.com/science/article/pii/S221371652200176X

Similar Items